Evidence map›Paper›PMID 28114833›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2017

A mechanistic kinetic description of lactate dehydrogenase elucidating cancer diagnosis and inhibitor evaluation.

Peifeng Tang, Jianlin Xu, Christopher L Oliveira, Zheng Jian Li, Shijie Liu

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peifeng Tanga Department of Paper and Bioprocess Engineering , SUNY ESF , Syracuse , NY , USA.
Jianlin Xub Biologics Process Development, Global Manufacturing and Supply , Bristol-Myers Squibb Company , Devens , MA , USA.
Christopher L Oliveirab Biologics Process Development, Global Manufacturing and Supply , Bristol-Myers Squibb Company , Devens , MA , USA.
Zheng Jian Lib Biologics Process Development, Global Manufacturing and Supply , Bristol-Myers Squibb Company , Devens , MA , USA.
Shijie Liua Department of Paper and Bioprocess Engineering , SUNY ESF , Syracuse , NY , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a key enzyme for glycolysis, lactate dehydrogenase (LDH) remains as a topic of great interest in cancer study. Though a number of kinetic models have been applied to describe the dynamic behavior of LDH, few can reflect its actual mechanism, making it difficult to explain the observed substrate and competitor inhibitions at wide concentration ranges. A novel mechanistic kinetic model is developed based on the enzymatic processes and the interactive properties of LDH. Better kinetic simulation as well as new enzyme interactivity information and kinetic properties extracted from published articles via the novel model was presented. Case studies were presented to a comprehensive understanding of the effect of temperature, substrate, and inhibitor on LDH kinetic activities for promising application in cancer diagnosis, inhibitor evaluation, and adequate drug dosage prediction.

Indexed as

Molecular Dynamics SimulationEnzyme InhibitorsHumansKineticsL-Lactate DehydrogenaseNeoplasmsTemperatureEnzyme InhibitorsL-Lactate DehydrogenaseCancer diagnosisinhibitor evaluationkinetic modellactate dehydrogenaseoligomeric enzyme

Identifiers

PMID28114833
PMCPMC6010104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.